4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-24-071532
Director bought 558,824 shares at $17.00 ($9,500,008)
- Director acquired 1,392,738 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HEALY JAMES Director | 2024-06-10 | Conversion | +1,392,738 | 1,392,738 | I | ||
| HEALY JAMES Director | 2024-06-10 | Purchase | +470,589 | $17.00 | $8,000,013 | 1,863,327 | I |
| HEALY JAMES Director | 2024-06-10 | Purchase | +18,641 | $17.00 | $316,897 | 18,641 | I |
| HEALY JAMES Director | 2024-06-10 | Purchase | +17,861 | $17.00 | $303,637 | 17,861 | I |
| HEALY JAMES Director | 2024-06-10 | Purchase | +26,278 | $17.00 | $446,726 | 26,278 | I |
| HEALY JAMES Director | 2024-06-10 | Purchase | +25,455 | $17.00 | $432,735 | 25,455 | I |
| Derivatives | |||||||
| HEALY JAMES Director | 2024-06-10 | Conversion · Series B Preferred Stock | −11,924,138 | 0 | I | ||
| Open-market purchases · 558,824 sh · avg $17.00 · $9,500,008 | |||||||
Loading xslF345X05/ownership.xml…